Agnes, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 7.592
EU - Europa 6.141
AS - Asia 5.911
SA - Sud America 1.059
AF - Africa 146
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 13
Totale 20.878
Nazione #
US - Stati Uniti d'America 7.404
SG - Singapore 2.631
DE - Germania 2.006
CN - Cina 1.620
SE - Svezia 941
BR - Brasile 876
IT - Italia 640
UA - Ucraina 619
FR - Francia 537
VN - Vietnam 506
IE - Irlanda 299
GB - Regno Unito 296
FI - Finlandia 239
PL - Polonia 207
ID - Indonesia 177
IN - India 175
JP - Giappone 159
TR - Turchia 102
HK - Hong Kong 101
RU - Federazione Russa 94
BD - Bangladesh 92
CA - Canada 89
AR - Argentina 72
IQ - Iraq 63
MX - Messico 61
BE - Belgio 58
ZA - Sudafrica 49
KR - Corea 47
NL - Olanda 34
IR - Iran 33
SA - Arabia Saudita 30
ES - Italia 29
PK - Pakistan 28
AT - Austria 25
EC - Ecuador 24
VE - Venezuela 24
LT - Lituania 22
CO - Colombia 21
MA - Marocco 17
UZ - Uzbekistan 17
CH - Svizzera 16
KE - Kenya 16
PH - Filippine 14
AE - Emirati Arabi Uniti 13
CI - Costa d'Avorio 13
CL - Cile 13
EU - Europa 13
CZ - Repubblica Ceca 12
PY - Paraguay 12
RO - Romania 12
TH - Thailandia 12
EG - Egitto 11
TN - Tunisia 11
DZ - Algeria 10
NP - Nepal 10
AU - Australia 9
AZ - Azerbaigian 9
JO - Giordania 9
IL - Israele 7
JM - Giamaica 7
LV - Lettonia 7
PA - Panama 7
PT - Portogallo 7
TW - Taiwan 7
UY - Uruguay 7
BY - Bielorussia 6
MY - Malesia 6
BG - Bulgaria 5
BH - Bahrain 5
CR - Costa Rica 5
DK - Danimarca 5
ET - Etiopia 5
GR - Grecia 5
PE - Perù 5
DO - Repubblica Dominicana 4
EE - Estonia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
OM - Oman 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AO - Angola 3
CY - Cipro 3
GA - Gabon 3
GE - Georgia 3
HN - Honduras 3
KW - Kuwait 3
LB - Libano 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AL - Albania 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BZ - Belize 2
GD - Grenada 2
GT - Guatemala 2
GY - Guiana 2
HR - Croazia 2
Totale 20.852
Città #
Singapore 1.322
Chandler 989
Ashburn 802
San Jose 676
Jacksonville 350
Beijing 293
Dublin 292
San Mateo 273
Ann Arbor 203
Nanjing 189
New York 187
Ho Chi Minh City 169
Jakarta 160
Los Angeles 158
Lauterbourg 157
The Dalles 152
Tokyo 142
Warsaw 141
Hanoi 135
Rome 132
Hefei 130
Boston 125
Munich 122
Wilmington 119
Woodbridge 115
Nürnberg 112
Marseille 104
Frankfurt am Main 102
Milan 94
Dearborn 92
Seattle 92
Helsinki 91
Lawrence 91
Chicago 85
Bremen 83
Hong Kong 83
Redwood City 81
Cattolica 80
Houston 80
Dallas 77
Nanchang 70
Izmir 69
Santa Clara 69
São Paulo 65
Moscow 64
Buffalo 60
Shenyang 60
Hangzhou 58
Fairfield 57
Princeton 53
Brussels 52
Zhengzhou 48
Lancaster 47
Hebei 42
University Park 39
Tianjin 38
Augusta 37
Shanghai 36
Detroit 34
Council Bluffs 33
Johannesburg 33
London 33
Mountain View 33
Andover 32
Atlanta 31
Changsha 31
Nuremberg 31
Da Nang 30
Toronto 30
Guangzhou 29
Kent 29
Belo Horizonte 28
Boardman 28
Kraków 28
Phoenix 28
Rio de Janeiro 28
Seoul 28
Paris 27
Tukwila 27
Turku 27
Baghdad 26
Kunming 26
Norwalk 26
Dhaka 22
Pune 22
Brooklyn 20
Curitiba 20
Jiaxing 20
Mexico City 20
Orem 20
Chengdu 19
Düsseldorf 19
Jinan 19
Kish 18
Memphis 18
Mumbai 18
Cambridge 17
Denver 17
Montreal 17
Chennai 16
Totale 10.902
Nome #
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 353
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs. 320
Liver Transplantation in Alcoholic Patients: Impact of an Alcohol Addiction Unit Within a Liver Transplant Center 253
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 247
Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant 235
Molecular adsorbent recirculating system in liver transplantation: Safety and efficacy.- 222
Duplex Doppler in the postoperative monitoring of liver transplant recipients 205
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 205
Lumbar chemical sympathectomy in end stage of arterial disease: early and late results 190
Optimization of Donor-Recipient match and identification of the futile match cutoff. A national italian study on liver transplantation. 190
Liver transplantation in patients with alcoholic liver disease: A retrospective study 189
Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome 185
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 184
Use of an esophageal echo-Doppler device during liver transplantation: preliminary report 183
Thromboelastography does not reduce transfusion requirements in liver transplantation: A propensity score-matched study 180
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 178
Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center 168
Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review 167
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 164
Enteric-coated mycophenolate sodium: one-way conversion from mycophenolate mofetil and de novo use in stable liver transplant recipients 163
Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match 159
http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation 159
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 158
Enzymatic determinations in acute rejection after liver transplantation: preliminary report on necrosis index 158
Comparative evaluation of two perfusion solutions for liver preservation and transplantation. 158
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 158
Fungal infections after liver transplantation: incidence and outcome 156
Pediatric T-tube in adult liver transplantation: Technical refinements of insertion and removal 156
Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation 155
Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation 154
Liver transplantation for hepatitis B virus patients: long-term results of three therapeutic approaches 152
Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association 152
Intra-operative parathyroid hormone monitoring through central laboratory is accurate in renal secondary hyperparathyroidism. 151
Prediction of 6-month survival after liver transplantation using Cox regression. 150
Psychological risk factors for graft rejection among liver transplant recipients 150
Molecular adsorbent recirculating system (Mars) in patients with primary nonfunction and other causes of graft dysfunction after liver transplantation in the era of extended criteria donor organs 149
Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report 149
Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives 149
Mitochondrial liver enzymes and the ratio between mitochondrial and cytoplasmic enzymes in the differential diagnosis of acute rejection after liver transplantation 148
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 148
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 148
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients 147
D-MELD, a strong and accurate tool to guide donor-2-recipient matching 146
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 146
Orpitt: a computerized chart for intraoperative real time management of liver transplant data 145
[Blood recovery and autotransfusion within integrated transfusion systems during liver transplantation. The authors' own experience] 144
-Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 143
Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 142
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV patients. 142
Is primary nonfunction still a suitable indication for liver retransplantation? 142
Waiting list mortality and 5-year transplant survival benefit of patients with MASLD: An Italian liver transplant registry study 141
The nonstandard liver, a hidden resource that cannot be overlooked: implications for the identification of the best recipient. 141
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 141
High intraoperative blood product requirements in liver transplantation: Risk factors and impact on the outcome 140
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 137
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 137
Model for end-stage liver disease dynamic stratification of survival benefit 136
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 136
Anidulafungin--a new therapeutic option for Candida infections in liver transplantation 135
Donor risk index and organ patient index as predictors of graft survival after liver transplantation 135
Overextended Criteria Donors: Experience of an Italian Transplantation Center 134
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 133
Preliminary experience using N-butyl cyanoacrylate for management of bleeding after percutaneous transhepatic biliary drain placement: a technical note 132
Psychological risk factors for graft rejection among liver transplant recipients 132
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 131
Migration rate using Fully-covered metal stent in anastomotic strictures after liver transplantation: Results from the BASALT Study Group 131
Availability of a Web and Smartphone Application to Stratify the Risk of of Early Allograft Failure Requiring Liver Retransplantation 130
Treatment of chronic hepatitis C virus infection with pegylated interferon and ribavirin in cirrhotic patients awaiting liver transplantation 130
Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation 130
Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles 129
-Allocation of nonstandard livers to transplant candidates with high MELD scores: Should this practice be continued? 129
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 129
Role of alpha-fetoprotein in selection of patients with hepatocellular carcinoma waiting for liver transplantation: must we reconsider it? 128
Paradoxical effect of short-term protein loading on CsA-treated kidney transplant recipients 127
Results of liver transplantation for hepatitis delta disease without immunoprophylaxis 127
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center 127
The mismatch choice in liver transplantation: a suggestion for the selection of the recipient in relation to the characteristics of the donor. 126
A Case of Insulinoma Detected by 68Ga-DOTANOC PET/CT and Missed by 18F-Dihydroxyphenylalanine PET/CT 126
Pregnancy After Liver Transplant: Neonatal Outcomes and Long-Term Maternal Follow-up 126
Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study 125
Quantification of degree of steatosis in extended criteria donor grafts with standardized histologic techniques: implications for graft survival 125
Duplex Doppler evidence of high hepatic artery resistive index after liver transplantation: Role of portal hypertension and clinical impact 125
CONUT Score Predicts Early Morbidity After Liver Transplantation: A Collaborative Study 123
Model for End-stage Liver Disease Dynamic Stratification of Survival Benefit 122
Lamivudine-induced muscle mitochondrial toxicity 122
Pancreatic function assessment 122
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 122
Indocyanine green clearance tests to assess liver transplantation outcomes: a systematic review 121
Mitochondrial/cytoplasmic enzyme ratio for the diagnosis of acute rejection after liver transplantation: sensitivity and specificity 121
Donor Risk Index and Organ Patient Index as Predictors of Graft Survival After Liver Transplantation 119
Prediction of 6-month survival after liver transplantation using Cox regression 117
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 117
Personalized Therapy in a Multidisciplinary Team Improves Survival in Patient with HCC: The Hepatocatt Experience 116
Prognostic value of MELD score and donor quality in liver transplantation: implications for the donor recipient match. 116
Primary difunction after liver trasplantation: donor or recipients fault? 116
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 116
Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis 116
Intraoperative trends of oxygen consumption and blood lactate as predictors of primary dysfunction after liver transplantation 115
Possibility of recognizing immunologic and cyclosporine A damage by urinary neopterin excretion in kidney transplant recipients 114
Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation 111
Totale 15.032
Categoria #
all - tutte 84.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.570


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 0 0 24
2021/20221.456 88 187 28 105 71 47 10 259 62 83 199 317
2022/20232.818 323 364 260 434 183 364 149 210 311 70 120 30
2023/20241.356 55 428 39 148 58 176 89 43 16 49 128 127
2024/20252.991 45 79 237 114 277 80 80 146 472 307 653 501
2025/20267.019 1.192 184 436 748 1.217 345 1.287 324 436 523 283 44
Totale 21.088